What is nanomedicine?

Nanomedicine is the application of nanotechnology to achieve innovation in healthcare. It uses the properties developed by a material at its nanometric scale 10-9 m which often differ in terms of physics, chemistry or biology from the same material at a bigger scale.

Moreover, the nanometric size is also the scale of many biological mechanisms in the human body allowing nanoparticles and nanomaterials to potentially cross natural barriers to access new sites of delivery and to interact with DNA or small proteins at different levels, in blood or within organs, tissues or cells.

Know more

ETPN strategic inputs

As a major pan-European industry-oriented initiative, the ETPN aims at strengthening Europe’s capabilities and competitiveness in the area of nanomedicine innovation. Since 2005 the ETPN published a number of strategic documents outlining the needs and roadmaps for nanomedicine research in Europe. We have contributed to set up numerous European funded projects providing a first impression of the conditions for a suitable social and economic environment and the structural requirements for an efficient translation of R&D results into innovative nanomedicine.

Know more

ETPN support to innovation

Complementary to its strategic inputs as an ETP to shape and support public funding on the most promising areas of Nanomedicine, the ETPN has designed in 2014 unique technical infrastructures regrouped in a central instrument: the Nanomedicine Translation HUB. These free of charge services support and accelerate the development of the best Nanomedicine projects from innovative design to clinical development.

Know more

Key reasons to become a member:

Meet new partners and end-users
Share your success stories
Benefit from unique advantages
Shape the future of Nanomedicine in europe
Promote and educate

Know more

EuroNanoMed III: announced transnational call for proposals (2019) for European innovative projects in Nanomedicine

Oct 15, 2018

PRELIMINARY ANNOUNCEMENT Under the umbrella of EuroNanoMed III (official website), the 10th Joint Transnational Call will be launched for funding multilateral innovative research projects on nanomedicine. This call is likely to open on: 14th November 2018 Submission...

Nanobiotix won the Pharma Company of the Year award at CPhIAwards

Oct 10, 2018

Nanobiotix, the late clinical-stage Nanomedicine company and Platinum member of the ETPN has been rewarded during the ceremony 2018 of the CphI Awards on October 9 in Madrid, Spain. Nanobiotix won Pharma Company of the Year Laurent Lévy, CEO of Nanobiotix, won CEO of...

Greet NOBEL meeting in Milano

Oct 10, 2018

Very nice meeting of the NOBEL Project last week in Milano, greatly hosted and organized by Fondazione Don Carlo Gnocchi ONLUS. Two days to sharper our strategy for a #HealthTech ecosystem in Europe. Amazing visit of Don Gnocchi rehabilitation facilities including...